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Abstract
Adults with metabolic syndrome (MetS) are at a high risk for developing type II diabetes 
and cardiovascular disease. As well, rural populations have lower access to lifestyle 
modifications (recreational centres) to manage this condition. Adults with MetS were 
recruited from rural southwestern Ontario. At each visit, resting blood pressure (BP) was 
measured, a predictive fitness (V02inax) test was offered and exercise was prescribed 
using the Step Test Exercise Prescription (STEP™). Home-monitoring technology 
included a Blackberry™, BP monitor and a pedometer. Clinical systolic BP (SBP) and 
diastolic BP (DBP) decreased from baseline to 3 months (VI) and continued to decrease 
into 6 months (V2). At-home SBP decreased at VI and was maintained at V2. At-home 
DBP followed the same pattern as clinical. A lifestyle intervention in primary care using 
STEP with home-monitoring technology decreased BP and increased fitness and quality 
of life in adults from rural communities with MetS.
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Cardiovascular disease (CVD), such as myocardial infarction and stroke, is the leading 
cause of death in Canadian men and women (Statistics Canada, 2004). Prominent risk 
factors include, but are not limited to, increased blood pressure (BP), abdominal obesity, 
low fitness, low levels of high density lipoprotein cholesterol (HDL), and increased 
fasting plasma glucose (American College of Sports Medicine, 1990; Campbell et al., 
2009; Canadian Diabetes Association, 2008; Pescatello & VanHeest, 2000).
When multiple CVD risk factors cluster together, they increase the risk of developing 
CVD greater than merely the sum of the risk factors (Aizawa et al., 2009). The common 
clustering of certain key risk factors has been identified and termed Metabolic Syndrome 
(MetS). More specifically, the National Institutes of Health Third Report of the National 
Cholesterol Education Program Expert Panel on Detection, Evaluation, and Treatment of 
High Blood Cholesterol in Adults (NCEP ATP III) defined MetS as a disorder where an 
individual has at least three of the following characteristics: waist circumference (WC) 
>102 cm for men and >88 cm for women; triglycerides >1.69 mmol/L; high density 
lipoprotein (HDL) <1.03 mmol/L in men and <1.29 mmol/L in women; fasting serum 
glucose > 6.1 mmol/L; and a resting arterial BP >130/85 mmHg (National Institutes of 
Health, 2002). Individuals classified as having MetS are also at a much greater risk of 
Type II Diabetes Mellitus (T2D) (Alberti et al., 2009). According to the Canadian 
Diabetes Association (CD A), individuals with T2D are at a greater risk of developing 
CVD and up to 80% of T2D will experience a fatal heart attack or stroke (Canadian 
Diabetes Association, 2008).
The prevalence of MetS increases with age and therefore the aging population is of 
greatest risk in developing MetS (Ford, Giles, & Dietz, 2002; Galassi, Reynolds, & He, 
2006). MetS is highly related to lifestyle choices made in the areas of exercise and 
nutrition (Virgin & Schmitke, 2003). Individuals with MetS tend to be on average, more 
overweight, less active and possess more risk factors for CVD than age matched controls.
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This leads to these individuals having elevated resting BP (hypertension), low fitness and 
increased serum glucose and lipid levels, each of which can individually increase the risk 
of developing CVD (Virgin & Schmitke, 2003).
Centralized obesity (abdominal fat) contributes to the development of CVD (Bjomtorp, 
1992) as well as metabolic diseases such as T2D (Pescatello & VanHeest, 2000). 
Increased abdominal fat, measured by WC, is a contributor to MetS. Obesity, as a result 
of an increased WC, has also become a major concern to the health care community due 
to the increasing cost of medical care for obesity related diseases and disabilities 
(Pescatello & VanHeest, 2000; Vega, 2001).
Hypertension is one of the most prevalent medical disorders and has been shown to lead 
to an increased incidence of CVD mortality. Hypertension is defined as >140 mmHg and 
>90 mmHg for systolic BP (SBP) and diastolic BP (DBP), respectively (Pescatello et al., 
2004). According to the 2008 Canadian Hypertension Education Program (CHEP), 
hypertensive patients have an increased risk of developing T2D due to the frequent 
clustering of cardiometabolic risk factors, especially when associated with central obesity 
(Campbell et al., 2009).
1.2 Metabolic syndrome and cardiovascular disease
The identification that a clustering of risk factors including hypertension, low levels of 
HDL and increased fasting blood glucose may be an underlying factor for future CVD 
was a concept proposed by Reaven (1988). This clustering of risk factors, now formally 
referred to as MetS has had a variety of different classifications: the two most widely 
used guidelines being from the previously mentioned NCEP ATP III definition (National 
Institutes of Health, 2002) and the World Health Organization (WHO) definition (Alberti, 
Zimmet, & WHO Consultation, 1998). A third, less widely used definition comes from 
the International Diabetes Federation (IDF) (Alberti, Zimmet, & Shaw, 2006).
The WHO definition includes glucose intolerance or diabetes mellitus and/or insulin 
resistance together with two or more of the following: raised arterial pressure >160/90
mmHg, raised plasma triglycerides (>1.7 mmol/L) and/or low HDL-cholesterol (<0.9 
mmol/L in men; <1.0 mmol/L in women), central obesity (waist to hip ratio >0.90 men; 
>0.85 women) and/or BMI >30 kg/m , and microalbuminuria (urinary excretion rate >20 
ug/min or albumin:creatinine ratio >20 mg/g). The ATP III definition was previously 
described.
Although these definitions allow for the early identification of at-risk individuals as a pre­
emptive fight against future CVD, the underlying issue is that these definitions would not 
identify the same people as having MetS and in turn, not classify them as at risk for CVD. 
In 2006 a meta-analysis was completed that addressed the issue of the two separate and 
widely used guidelines. Galassi et al. (2006) found that the use of the two definitions for 
MetS left inconsistent results for the association between MetS and the risk of CVD.
They identified 20 articles that met their eligibility criteria that included the use of WHO 
or ATP III definitions, an incidence or mortality of CVD, CHD, stroke, or all-cause 
mortality as an endpoint associated with MetS, and a prospective cohort study design. 
Follow-up of the studies ranged from 2.8 to 13.5 years. They found that overall, 
individuals defined as having MetS compared to those without MetS, had a relative risk 
(RR) of CVD of 1.61, meaning there is an increased risk of developing CVD with MetS 
(an RR <1 would indicate a reduced risk). When separating the studies into the WHO 
definition or the ATP III definition, individuals defined as having MetS by WHO criteria 
had a higher RR for CVD than with ATP III. This study also showed that MetS was 
associated with a higher incidence of coronary heart disease (RR 1.52) and stroke (RR 
1.76) as well as an increased risk of mortality from all causes (RR 1.35) and CVD (RR 
1.74) compared to no MetS. Galassi et al. attributed the higher RR of CVD with the 
WHO definition to the fact that the WHO requires the presence of insulin resistance 
while the ATP III was developed for clinical practice and therefore only requires fasting 
hyperglycemia. Individuals who are more insulin resistant are at greater risk for CVD 
(Galassi et al., 2006), therefore the WHO definition of MetS detects individuals who are 
at a greater risk than those detected by the ATP III definition. As well, the WHO has a 
higher threshold for BP than the ATP III, which may explain the greater RR associated 
with the WHO definition. This analysis was unable to conclude whether the WHO or
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ATP III definition had better predictive values. It has been shown however, that the ATP 
III definition for abdominal obesity, which is lower than the circumference cut offs for 
WHO, identified diabetes more frequently during a 4-year follow-up on men aged 40-64 
(Laaksonen et al., 2002).
The third definition, the IDF consensus worldwide definition of MetS, was released by 
the IDF in 2006 and is therefore the most recently released definition of MetS (Alberti et 
al., 2006). To be identified as having MetS according to the IDF definition, a person must 
have central obesity measured by WC. The IDF separates WC thresholds into ethnicities 
where the threshold for North Americans is the same as the ATP III and separate WC 
thresholds exist for European, Asian, and North American populations. Central and South 
America, Middle Eastern, Eastern Mediterranean and Africa do not have their own 
thresholds and are to use the corresponding data mentioned in the IDF publication. 
According to the definition, along with an increased WC, a person must also have (or 
treatment for) any two of the following: increased triglycerides (>1.7 mmol/L), decreased 
HDL (<1.3 mmol/L in males, <1.29 mmol/L in females), increased BP (SBP >130 mmHg 
or DBP >85 mmHg), or increased fasting blood glucose (>5.6 mmol/L) or previously 
diagnosed T2D. The IDF created these guidelines to address the need for a single, 
universally accepted definition that is simple to use in clinical practice.
1.3 Treating metabolic syndrome
In a proactive effort to reduce CVD-related mortality and concomitantly reduce health­
care costs, primary prevention has become a key objective of health-related research. 
Primary prevention is highly focused on physical activity, weight management, nutrition 
guidance, and in some cases pharmacological control. With respect to physical activity as 
a primary tool for prevention, studies have shown that individuals who engage in physical 
activity for most days of the week at a moderate to somewhat strong intensity (60-85% 
maximal oxygen uptake [VC^max]) tend to develop less risk factors for CVD.
Evidence supports an aggressive approach to treating the individual risk factors of MetS, 
which include hypertension, obesity and increased fasting blood glucose (Canadian
4
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Diabetes Association, 2008). Lowering elevated BP reduces the risk of future CVD. 
Rosenzweig et al. (2008) recommends that the type and intensity of BP lowering therapy 
be chosen for optimal risk reduction, safety, and cost-effectiveness. Specifically, that BP 
be reduced to less than 140/90 mmHg in individuals without diabetes through the use of 
lifestyle modifications and moving to medication if previous modifications are not 
successful. Lifestyle management needs to be the first-line therapy for individuals with 
MetS or those who are at an increased risk for CVD. This includes applying a program of 
weight reduction/maintenance depending on the need, by combining physical activity, 
diet, and behaviour modification programs to decrease body weight/WC below the targets 
indicated for MetS classification (National Institutes of Health, 2002; Rosenzweig et al., 
2008).
The ATP III (2002) stated the importance of treating individuals classified as having 
MetS with drastic lifestyle changes as a preventative measure against T2D (National 
Institutes of Health, 2002). The CDA guidelines also promote the identification of those 
with MetS and the treatment of the components of MetS as a means to significantly 
reduce the occurrence of cardiovascular morbidity and mortality. To address this, 
physical activity and increased cardiorespiratory fitness is recommended by the CDA to 
reduce T2D in both men and women (Canadian Diabetes Association, 2008).
1.3.1 Interventions in metabolic syndrome
The use of pharmacological control is necessary in some stages of MetS, such as in the 
case of uncontrolled hypertension. However a study by Knowler et al. (2002) showed that 
the use of the drug metformin (Glucophage) to control elevated fasting plasma glucose 
levels was not as effective in preventing diabetes as a lifestyle modification program that 
included increased physical activity and no pharmacological control. The lifestyle 
modification consisted of a 16-lesson curriculum covering diet, exercise, and behaviour 
modification to help participants achieve at least 150 minutes per week of moderate 
physical activity and a healthy low-calorie, low-fat diet. Therefore, to prevent T2D and 
future risk of CVD, lifestyle modification through increased physical activity, as well as 
diet, is recommended as primary prevention before the use of pharmaceuticals.
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Leisure-time physical activity, classified in categories of low-, medium-, or high-intensity 
activities has been shown to predict the development of MetS in men aged 40-60 
(Laaksonen et al., 2002). Using a sample of 612 men with no MetS at baseline,
Laaksonen et al. (2002) found that men who participated in >3 hours of leisure time 
physical activity were half as likely to have MetS compared to sedentary men at a 4 year 
follow-up (using the WHO and ATP III definitions of MetS). Adoption of an active 
lifestyle (aerobic exercise, 3 days/week, 30-40 minutes) in older adults (55-75 years) has 
also been shown to reduce the development of risk factors associated with MetS (SBP, 
cholesterol, triglycerides, insulin and WC) compared to age and location matched 
controls (Petrella, Lattanzio, Demeray, Varallo, & Blore, 2005).
In addition, leisure-time physical activity has also been shown to decrease the incidence 
of T2D. In a study by Helmrich, Ragland, Leung, and Paffenbarger (1991) male alumni 
(n = 5,990) were followed between 1962-1976 in which a total of 202 men developed 
T2D. They found leisure-time physical activity to be inversely related to the development 
of T2D. In the individuals with the highest risk for T2D (high BMI, hypertension, family 
history of T2D), the protective effect of vigorous physical activity was strongest. 
Individuals with a BMI >26 kg/m , had a much lower chance of developing T2D when 
leisure-time physical activity averaged >2000 kcal/week, even those averaging 500-1999 
kcal per week had a lower RR for developing T2D. The case is similar for a family 
history of hypertension, where those with a history were at a lower risk of developing 
hypertension if they averaged >500 kcal per week of leisure-time physical activity.
There have been several studies that have investigated lifestyle-based interventions in 
individuals with MetS. Katzmarzyk et al. (2003) identified participants from the 
HERITAGE Family study (Bouchard et al., 1995) {n = 621), as sedentary but otherwise 
healthy, to participate in a 20 week supervised aerobic training program. At baseline, 105 
participants (16.9%) had MetS and of those, 32 participants (30.5%) were no longer 
classified as having MetS after the training (using the ATP III definition of MetS). 
Training consisted of three supervised sessions per week on a cycle ergometer with a 
gradual increase in duration and intensity of training. Participants were instructed not to 
change their health or lifestyle habits outside of the study. Most participants who were no
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longer classified as having MetS after the training experienced a lowering of triglycerides 
(43%), followed closely by a lowering of BP (38%) and decreased WC (28%); improved 
HDL (16%) and fasting plasma glucose (9%) were not as prominent (Katzmarzyk et al., 
2003).
Carroll, Borkoles, and Polman (2007) used a non-dieting lifestyle intervention program to 
examine the short-term effects on fitness in premenopausal obese women with MetS 
(using the IDF definition of MetS). The intervention program consisted of structured, 
women only exercise classes in a community centre. Participants were also encouraged to 
accumulate a minimum of 4 hours of physical activity per week with at least two of those 
hours being participation in the structured exercise classes. Goal setting and problem 
solving for weight management were also employed. Thirty-one participants with MetS 
were randomized to receive either intervention or a waiting list control. Twenty 
individuals completed repeated baseline measures after the 3 month intervention period. 
The lifestyle group (n = 10) had a higher relative VC^max compared to the control group 
at 3 months as well as lower DBP and less additional IDF metabolic components.
The use of dietary modification as well as regular exercise has shown various 
improvements in risk factors of MetS including decreased BP, WC, fasting glucose, total 
cholesterol and LDL cholesterol levels. Aizawa, Shoemaker, Overend, and Petrella 
(2009) used a Mediterranean-style diet as well as at-home exercise prescribed according 
to baseline fitness level and stage of change. They compared individuals with MetS to 
those without MetS with the same intervention (using ATP III definition of MetS). After 
24 weeks they found both groups to experience a significant decrease in resting heart rate 
(RHR) and increased V02max. The 24 week BP decrease in those with MetS was - 
6.9±16.1 mmHg for SBP and -5.6±9.2 mmHg for DBP. Unfortunately, because of the 
implementation of a dietary as well as an exercise modification, a definite cause of the 
change could not be determined.
Carroll et al. (2007) also examined the effect of their non-dieting, exercise intervention 
on psychological well-being of the premenopausal obese women with MetS. They found
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that participants in the exercise intervention group experienced a 17.3% increase in 
general well-being score indicating an improvement in quality of life (QOL) despite the 
lack of change in body weight or composition. While physiological risk factors for CVDs 
are important to target in individuals with MetS, it has also been found that health related 
QOL is lowered in those with MetS (using the IDF definition of MetS) and therefore 
lifestyle interventions to improve risk factors in MetS should also positively effect QOL 
(Han et al., 2009; Ma, King, Wilson, Xiao, & Stafford, 2009).
QOL has been shown to improve with a lifestyle modification intervention in women 
with MetS from rural communities. Oh et al. (2010) randomly allocated 52 women with 
MetS (using the ATP III and WHO definitions) from rural communities into a 6 month 
therapeutic lifestyle program (n = 31) or a control group (n = 21). The therapeutic 
lifestyle program consisted of counselling, health education, exercise, and dieting. There 
was a significantly greater decrease in WC and body weight in the intervention group 
compared to the control. Using the Medical Outcomes Trust SF-36 (Ware & Sherboume, 
1992), Oh et al. observed significantly greater improvements in the intervention group in 
the areas of physical function, general health, vitality and mental health compared to the 
control group.
1.3.2 Exercise training to reduce risk factors associated with metabolic syndrome
Exercise training, as opposed to physical activity, has (also) been shown to improve risk 
factors for CVD including hypertension (Paffenbarger, Wing, Hyde, & Jung, 1983), 
development of diabetes (Canadian Diabetes Association, 2008), obesity (Pescatello & 
VanHeest, 2000) as well as physiological determinants of risk including arterial stiffness 
(Aizawa et al., 2009; Goldberg, Boaz, Matas, Goldberg, & Shargorodsky, 2009). For the 
purpose of the present study, exercise training will be defined as a subset of physical 
activity that is planned and supervised by a professional with the intention of increasing 
intensity, while physical activity is unsupervised exercise that results in energy 
expenditure including leisure-time, occupational, household or other activity (Caspersen, 
Powell & Christenson, 1985).
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In terms of hypertension and training-induced reductions in risk, a study conducted by 
Paffenbarger, Wing, Hyde and Jung (1983), followed male university alumni for 6-10 
years beginning 16-50 years after they graduated {n = 14,998). The investigators noted 
that although participation in varsity athletics, walking or light sports did not have an 
effect on the incidence of hypertension, a background presence of participation in 
vigorous sports did show a decreased incidence of hypertension among the male alumni 
(Paffenbarger et al., 1983). Other factors that increased the incidence of hypertension in 
the male alumni were weight gain since college (>11.5 kg), parental history of 
hypertension, overweight, as well as lack of participation in vigorous sports. Therefore, 
due to research similar to the study previously mentioned, physical fitness has been 
widely accepted as a preventative measure to mortality from CVDs and as such, 
guidelines have been created to quantify the minimum amount necessary to improve or 
maintain health.
The American College of Sports Medicine (ACSM) recommends at least 5 days per week 
of moderate intensity (40-60% of VC^reserve) aerobic activities and at least 3 days per 
week of vigorous intensity (>60% VC^reserve) aerobic exercise with 2-3 days a week of 
muscular strength and endurance and resistance exercise (American College of Sports 
Medicine, 1990; American College of Sports Medicine, Thompson, Gordon, &
Pescatello, 2010). A combination of moderate and vigorous intensity exercise is ideal for 
improvements in health and fitness in most adults. When choosing the exercise modality 
to include in an exercise program the ACSM recommends taking consideration into the 
individual’s goals, physical ability, health status and available equipment. The quantity of 
exercise is a function of frequency, intensity and duration of the exercise performed and 
reflects a dose-response relationship between the volume of exercise and the health and 
fitness benefits from it (American College of Sports Medicine, 1990; American College 
of Sports Medicine et al., 2010; Church, Earnest, Skinner, & Blair, 2007). Even small 
increases in the volume of exercise performed could improve health or fitness; with the 
greatest improvements seen in sedentary individuals. The duration component of 
exercise, can be performed in one session a day or accumulated throughout the day with 
multiple sessions of activity at a minimum of 10 minutes each (American College of
Sports Medicine et al., 2010). Overall, the exact composition of frequency, intensity, 
time, or type (FITT) of exercise will vary depending on an individual’s abilities and goals 
including their health status and exercise tolerance.
With respect to resistance training, recommendations put forth by the ACSM suggest that 
individuals with hypertension perform resistance exercises only in conjunction with an 
aerobic/endurance exercise program (with the exception of circuit training) (American 
College of Sports Medicine, 1993). Referring to a resistance program for individuals with 
MetS, low levels of resistance training may improve metabolic risk factors, however data 
on high levels of resistance training are not yet conclusive (Strasser, Siebert, & 
Schobersberger, 2010). Goals for a resistance program should be to decrease the 
physiological stress of everyday activities on the individual and to manage, postpone and 
possibly prevent future diseases.
The ACSM recognizes individuals with MetS (as defined using the ATP III guidelines) 
as a clinical population and therefore has developed treatment recommendations in 
addition to the previously mentioned guidelines. Treatment guidelines for MetS focus on 
weight control, physical activity, and treatment of possible CVD risk factors that could 
include pharmacotherapy (American College of Sports Medicine et al., 2010; National 
Institutes of Health, 2002). With individuals who have MetS, ACSM recommends initial 
exercise training to be performed at a moderate intensity and increasing to vigorous 
training when appropriate for greater improvements in health and fitness. Because of the 
high chance of individuals with MetS being overweight or obese, ACSM also 
recommends gradually increasing exercise levels to reach the 60 minutes of aerobic 
exercise 5 days a week, specifically focusing on a minimum of 10 minutes sessions 
accumulated throughout the day.
In January 2011, the Canadian Society for Exercise Physiology (CSEP) announced the 
release of new Canadian Physical Activity Guidelines (Tremblay et al., 2011). They state 
that adults and older adults need at least 150 min per week of moderate- to vigorous- 
intensity physical activity. The greater the variety, intensity and duration of the exercise
10
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performed, the greater the health benefit. In agreement with the ACSM, CSEP 
recommends individuals who are physically inactive (sedentary) to perform amounts 
below the recommended levels. For these adults, health benefits will be seen with lower 
amounts and require the use of gradual increases in frequency, intensity, and duration to 
meet the recommended guidelines.
Low physical fitness in those with MetS is associated with greater CVD risk. For 
example, using a longitudinal study design, Katzmarzyk, Church, and Blair (2004) have 
shown that low cardiorespiratory fitness (measured as relative VC^max) is an important 
risk factor for premature mortality in healthy men and men with MetS. The RR of 
mortality was the greatest in men with MetS who had the lowest level of fitness; the 
authors conclude that an increased cardiorespiratory fitness had a protective effect against 
mortality from CVD in healthy and MetS men. A prospective study of healthy men and 
women with an average follow up of 8 years showed that higher levels of physical fitness 
(measured by a timed treadmill test) could delay all-cause mortality primarily by a 
reduction in the rates of CVD and cancer (Blair et al., 1989); this effect was also noted in 
pre-hypertensive men (Kokkinos et al., 2009). It should be acknowledged however, that 
there may be differences in outcomes in studies addressing hypertension/pre-hypertension 
versus those where individuals have multiple risk factors of MetS and therefore 
extrapolation of the results should be applied to individuals who most resemble the 
population tested.
1.3.3 Mechanisms of exercise-based benefits in metabolic syndrome
The potential mechanisms responsible for decreases in BP with exercise include 
neurohumoral, vascular and structural adaptations. Decrease in total peripheral resistance 
appears to be the primary mechanism that reduces resting BP after exercise, specifically 
through changes in vessel diameter, where small changes in diameter can have a large 
impact on vascular resistance (Knowler et al., 2002; Pescatello et al., 2004). Training 
decreases sympathetic nerve activity (SNA) and therefore may prevent the vascular 
changes that are associated with increased BP or hypertension since an increase in SNA 
is a hallmark of hypertension (Abboud, 1982; Knowler et al., 2002; Pescatello et al.,
2004). Additionally, exercise training changes the vascular responsiveness to 
norepinephrine and endothelin-1, both effective vasoconstrictors, as well as increases the 
production of nitric oxide which improves vasodilation in otherwise healthy adults 
(Pescatello et al., 2004).
1.4 Exercise prescription in primary care
Primary care physicians have the first line of contact with individuals who have MetS as 
they have not yet been diagnosed with T2D or CVD. Therefore primary care may be the 
optimal grounds for identifying and treating these individuals to avoid future CVD or 
T2D (Grandes et al., 2009; Kraushaar & Kraemer, 2009; Petrella & Lattanzio, 2002). 
Petrella and Wight (2000) randomly surveyed 362 Canadian general or family physicians 
from rural and urban populations and found that only 67.4% of physicians felt confident 
in their exercise prescriptions but 93.8% were interested in improving these skills.
Petrella, Lattanzio, and Overend (2007) identified barriers that Canadian family 
physicians have found to be responsible for the decreased percent of exercise being 
prescribing at the primary care level. These barriers include, but are not limited to, a lack 
of skill in prescribing exercise and a lack of standard office testing equipment (Grandes et 
al., 2008; Petrella et al., 2007).
1.4.1 Step Test and Exercise Prescription
In 2000, the Step Test and Exercise Prescription (STEP™) tool was developed by 
Petrella and Wight (2000) to address the lack of primary care physicians who were 
counselling their patients about their exercise habits. It is an office-based instrument to be 
used at the primary care level to eliminate some of the barriers physicians face with 
exercise counselling. The STEP™ consists of a stepping test to predict V02max and a 
prescription portion that includes determining the level of fitness and training heart rate 
(HR) of the patient (Petrella, Koval, Cunningham, & Paterson, 2001). Petrella and Wight 
compared two types of counselling in the primary care setting, one using the ACSM 
guidelines (American College of Sports Medicine, 1990) and another using counselling 
plus the STEP™ administered by 293 of the surveyed physicians. While results showed a
12
longer time to administer the STEP™ than ACSM counselling, there was also a 
significant improvement in physician confidence and knowledge using STEP™.
The STEP™ was validated in 2001 for the use in older adults to predict VC^max (Petrella 
et al., 2001). The test-retest correlation coefficients for VC^max (ml/kg/min) were 0.97 
for men and 0.98 for women. There were no observed differences in predicted versus 
measured VC^max and the test showed sensitivity to change in both groups. The 
STEP™, compared to regular counselling using ACSM guidelines, showed a greater 
increase in VC^max as well as a decrease in SBP and BMI after 12 months of 
intervention in healthy older adults (n = 284, aged >65 years) (Petrella, Koval, 
Cunningham, & Paterson, 2003).
STEP™ has also been administered to individuals with MetS. In 2009, STEP™ was 
administered along with a dietary intervention to significantly reduce SBP, DBP, WC, 
fasting glucose levels, and improved carotid artery distensibility and beta stiffness index 
(Aizawa et al., 2009). Stuckey et al. (in press), as a pilot for the current study, used 
STEP™ in rural populations to increase daily physical activity and fitness and showed 
significant improvements in DBP and VC^max. As well, psychological data with the 
STEP™ has shown an increase in exercise self-efficacy among elderly community 
dwelling adults (Petrella et al., 2003), there is no data yet on the effect of STEP™ on 
health related QOL.
1.4.2 Primary care and technology
To assist with at-home lifestyle changes, technology is becoming more popular in the 
management of diabetes and MetS. Changes in behaviour including increased physical 
activity, weight reduction and self-monitoring of blood glucose and BP are recommended 
and are thought to positively impact cardiovascular health (Logan et al., 2007; Ma et al., 
2009).
A simple and inexpensive piece of technology validated for use in research and practice 
is the pedometer (Tudor-Locke, Williams, Reis, & Pluto 2002). Pedometers are used as
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an assessment tool for daily exercise levels as well as a motivational tool for physical 
activity behaviour where an index of required steps/day is used to guide the individual 
wearing the pedometer (Tudor-Locke & Bassett Jr., 2004). The use of pedometers is also 
supported by the ASCM to assess the quantity of exercise (American College of Sports 
Medicine et al., 2010).
Russell-Minda et al. (2009) looked at the effectiveness, feasibility and compliance of 
self-monitoring technology in individuals with type I or T2D. The review included self- 
monitoring of blood glucose, pedometers, and cell phone or wireless technologies. The 
self-monitoring of blood-glucose was shown to be effective in managing diabetes 
however, the results of the review indicate a need for further research in the area of 
technology on diabetes as well as other areas of health including CVD.
Some recent studies have shown that reminders sent to study participants using cell phone 
or text messaging (via cell phone) will help the patient to respond positively to the 
requested behaviour change (Faridi et al., 2008; McKay, King, Eakin, Seeley, &
Glasgow, 2001). Recently, Park, Kim, and Kim (2009), looked at the effect of an 8 week 
intervention using short message service (SMS; text messages) through a cellular phone 
on BP, weight, and serum lipids in obese and hypertensive patients. The intervention 
group (n = 28) was required to record BP and weight weekly on an internet-based diary 
through either the internet or by cell phone. There was a significant decrease in both SBP 
and DBP in the intervention group and no change in the control group (« = 21). Body 
weight, WC and HDL cholesterol each improved in the intervention group with no 
change or worsening in the control group with no access to the internet-based diary. 
Throughout the study, the intervention group received SMS from the research team nurse 
regarding education on diet, exercise, medication adjustment and body weight levels.
1.5 Rationale for study
Exercise-intervention studies have shown that supervised and structured aerobic training 
has the ability to decrease the risk factors of T2D and CVD in individuals with and
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without MetS. However, to date they have not examined at-home aerobic exercise 
prescription in the primary care setting within rural communities. Since primary care 
physicians are the first to access individuals with MetS but are not regularly visited by 
individuals from rural populations, examining the effect of prescriptive exercise using the 
STEP™ in combination with remote technology may provide insight for additional 
means to manage T2D and CVD in rural areas. It is hypothesized that a 6 month 
intervention using exercise prescribed with the STEP™ protocol at the primary care level 
in combination with remote monitoring technology will decrease SBP and DBP as well 
as increase VC^max and QOL in individuals with MetS from rural southwestern Ontario.
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Effect of the STEP Protocol and Home-Monitoring Technology in Rural Primary 
Care on Blood Pressure and Fitness in Metabolic Syndrome
2.1 Introduction
Cardiovascular diseases (CVDs), such as myocardial infarction and stroke, are the 
leading causes of death in Canadian men and women (Statistics Canada, 2004). When 
multiple CVD risk factors cluster together, an individual’s risk of developing CVD is 
greater than merely the sum of the risk factors (Aizawa et al., 2009). The clustering of 
three out of five key risk factors has been identified and termed metabolic syndrome 
(MetS); specifically, high blood pressure (BP), low HDL, high fasting glucose, high 
triglycerides and high waist circumference (WC) (National Institutes of Health, 2002). 
Individuals diagnosed as having MetS are also at a greater risk for Type II Diabetes 
Mellitus (T2D) (Alberti et al., 2009). According to the Canadian Diabetes Association 
(CDA), individuals with T2D are at a greater risk of CVD, as up to 80% of individuals 
with T2D will experience a fatal heart attack or stroke (Canadian Diabetes Association, 
2008).
Exercise training is a hallmark intervention to increase fitness and lower CVD risk in 
non-clinical and clinical populations, including those with MetS, T2D and CVD 
(American College of Sports Medicine, Thompson, Gordon, & Pescatello, 2010). 
Exercise training interventions are efficacious in decreasing the specific CVD risk factors 
in individuals with and without MetS (Aizawa, Shoemaker, Overend, & Petrella, 2009; 
Carroll, Borkoles, & Polman, 2007; Church, Earnest, Skinner, & Blair, 2007; Dunn et al., 
1997; Katzmarzyk et al., 2003; Katzmarzyk, Church, & Blair, 2004; Oh et al., 2010). 
High BP is one of these specific CVD risk factors and is important to control in those 
with MetS because the clustering of risk factors within MetS contributes to the 
development and progression of hypertension (Cheung et al., 2008; Hagberg, Park, & 
Brown, 2000). As many individuals with MetS have not yet been diagnosed with T2D or 
CVD, primary care physicians are often the first line of contact to identify and treat these
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individuals in an effort to avoid future complications (Grandes et al., 2009; Kraushaar & 
Kraemer, 2009; Petrella & Lattanzio, 2002).
The Step Test and Exercise Prescription (STEP™) is a tool designed for use by 
physicians in the primary care setting as a means of testing fitness and providing exercise 
and nutritional counselling (Aizawa et al., 2009; Petrella, Koval, Cunningham, & 
Paterson, 2001). Exercise counselling has been shown to increase fitness (as assessed via 
maximal aerobic capacity; VC^max) and decrease resting arterial blood pressure (BP; a 
prominent CVD risk factor) similarly to exercise training in a supervised environment 
(Dunn et al., 1997; Dunn et al., 1999). The use of STEP™, in combination with a dietary 
intervention, in primary care has been shown to increase fitness and decrease resting BP 
in individuals with MetS (Aizawa et al., 2009). However, the effect of the STEP™ on the 
quality of life (QOL) of individuals with MetS has yet to be considered.
The use of home-monitoring technology in primary care, such as cell-phones, internet 
and pedometers has shown encouraging results in the management of hypertension, 
diabetes, obesity, and physical inactivity by decreasing BP, fasting glucose levels and 
body weight (Logan et al., 2007; Ma, King, Wilson, Xiao, & Stafford, 2009; McKay, 
King, Eakin, Seeley, & Glasgow, 2001; Park, Kim, & Kim, 2009; Tudor-Locke,
Williams, Reis, & Pluto, 2002). The combination of primary care and home-monitoring 
technology may be beneficial for the rural population as they tend to have less access to 
physicians compared to urban populations. However, combining technology with primary 
care interventions has not been investigated to date.
Therefore, the purpose of this study was to evaluate the effectiveness of a 6 month 
aerobic-based exercise intervention in primary care using STEP™ with home-monitoring 
technology to improve prominent CVD risk factors associated with MetS in adults from 
rural southwestern Ontario as a means to address the lack of physicians available in the 
area as well as the high occurrence of T2D. Primary outcomes of the study were SBP and 
DBP, both in the clinic and at-home. VOimax and QOL were secondary outcomes while 
weight, BMI, WC, and RHR were tertiary outcomes. It was hypothesized that a 6 month
intervention using the STEP™ protocol with remote home-monitoring technology will 
decrease systolic BP (SBP) and diastolic BP (DBP) as well as increase VC^max and 
improve QOL in individuals with MetS.
2.2 Methods 
Participants
Sixty one adults (18-70 years of age) from rural southwestern Ontario (Huron, Perth and 
Grey-Bruce counties) with MetS were recruited for this study using a variety of social 
marketing techniques including posters, newspaper and radio advertisements. Rural 
residency was confirmed by postal code and proximity to the clinic. Recruitment 
occurred from October 2009 to June 2010. MetS was defined as having at least two of the 
following risk factors: SBP >130 mmHg or DBP >85 mmHg; high density lipoprotein 
cholesterol (HDL) <1.29 mmol/L in women and <1.03 mmol/L in men; fasting serum 
glucose of >6.1 mmol/L; triglycerides >1.69 mmol/L; and WC >102 cm for men and >88 
cm for women (National Institutes of Health, 2002). Interested participants were screened 
both on the phone and at the initial visit. Exclusion criteria for the study included: mean 
SBP >180 mmHg and/or DBP >110 mmHg, uncontrolled hypertension, type I diabetes, 
history of myocardial infarction, angioplasty, coronary artery bypass or cerebrovascular 
ischemia/stroke, unstable cardiac health, unstable pulmonary disease, use of medications 
known to affect heart rate, second or third degree heart block, history of alcoholism, drug 
abuse or other emotional, cognitive or psychiatric problems, a pacemaker, uncontrolled 
diabetes, orthopaedic problems that could impair ability to exercise, started, or changed 
dose of, a lipid lowering agent(s) within the previous 3 months and being currently 
enrolled in a clinical research trial.
Study Design
This study is part of the larger, ongoing, ARTEMIS (A multi-center, prospective, 
Randomized study To determine the effects of Exercise Managed Intervention Study) 
study looking at the effects of exercise and technology on the risk factor status of 
individuals with MetS. ARTEMIS is a 12 month study examining technology versus 
usual care in rural and urban populations with MetS. The outcome measures in
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ARTEMIS include BP, weight, WC, body mass index (BMI), VC^max, resting heart rate 
(RHR), stage of change model developed by Prochaska and Diclemente (1983), vascular 
function (flow mediated dilation, arterial compliance and distensibility, vascular 
conductance and resistance), muscle sympathetic nerve activity, heart rate variability, 
blood composition (low density lipoprotein cholesterol [LDL], HDL, glucose, 
catecholamines, triglycerides, estrogen, HgbAlC, insulin, hs-CRP), behavioural changes 
(QOL, self-efficacy, decisional balance, diabetes self-care activities), and 
satisfaction/comfort with technology. The present study was the first 6 months of the 
exercise intervention component of ARTEMIS, evaluating the effects of a 6 month 
aerobic exercise program on the BP, fitness (VC^max), and QOL in individuals with 
MetS. All participants had BP measurements, fitness evaluation, and QOL questionnaires 
before the study, halfway through the study (at 3 months) and upon completion of the 
study at 6 months. No nutritional guidance was given aside from providing and 
encouraging the use of the Canada’s Food Guide (Health Canada, 2007) in attempt to 
isolate the effect of the aerobic exercise. All participants were provided with a 
Blackberry™ (BlackBerry™ Curve 8300), home BP monitor (A & D Medical #UA- 
767PBT), and pedometer (Omron # HJ-150) for self-monitoring as part of the overall 
ARTEMIS study.
All visits were conducted at the Gateway Rural Health Research Institute in Seaforth, 
Ontario between November 2009 and December 2010. Gateway is a collection of rooms 
dedicated to research within the family health team primary care clinic in Seaforth. 
Participants arrived at the clinic fasted and without caffeine for 12 hours and were 
directed to Gateway by the family health team secretary at baseline (V0), 3 months into 
the study (VI) and 6 months into the study (V2).
The ARTEMIS study was approved by the University of Western Ontario REB #15828 
and study was funded by Canadian Institutes of Health Research Grant #CCT-83029, 
Heart and Stroke Foundation of Canada # PG-07-0364, and by the Canadian Diabetes 
Association.
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Measurement o f blood pressure and anthropometries
Resting brachial BP and heart rate (HR) were measured in the supine position by a 
trained health care professional with an automated sphygmomanometer (BpTRU™) on 
the left arm. Three measures were taken, each 2 minutes apart (Quinn et al., 2010). 
Recorded BP was measured as the average of SBP in the final two readings over the 
average of DBP in the final two readings. If the final two readings were greater than 5 
mmHg apart, a fourth BP measurement was made and the last three readings of SBP and 
DBP were averaged for the participant’s resting BP.
Anthropometries were then measured and included each participant’s weight, height, and 
WC. Weight (kg) was measured with a standard scale without shoes in the clothing worn 
by the participant at each visit. Height (cm) was measured without shoes at baseline and 
used throughout the study. WC (cm) was measured at each visit according to the National 
Institutes of Health measuring tape position for waist (abdominal) circumference, just 
above the uppermost lateral border of the iliac crest (National Heart, Lung, and Blood 
Institute, 1998).
MetS risk factors were measured at each visit; HDL, triglycerides and blood glucose were 
measured by a blood draw after a half hour rest. Blood analysis was completed by 
Gamma Dynacare Medical Laboratories, Brampton, Ontario. MetS risk factors were 
classified using the cut offs from the NCEP ATP III definition of MetS. We chose to use 
this definition because it was designed for clinical use and is a widely used definition of 
MetS in North America.
Step Test and Exercise Prescription
After at least one hour of rest (in which vascular measures were completed), the 
participant completed a submaximal aerobic fitness stepping test which is the first 
component of the STEP™ protocol (Petrella et al., 2001). The test was administered in a 
private, quiet room. The test consisted of stepping up and down a step measuring 20 cm 
high (includes both of the 2 steps, each 9.5cm), base is 40 cm wide and 60 cm deep. 
Participants were instructed to complete 20 steps at a pace they considered to be
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moderate. HR was measured before and after the step test. The time required to complete 
the test (seconds) and HR (beats per minute; bpm) after completion were used to predict 
maximal oxygen consumption (see Appendix A for VC^max calculation and ratings).
After calculation of predicted VC^max, participants were given individualized exercise 
prescriptions (second component of STEPrM) to increase their weekly aerobic and 
resistance exercise over the 3 months between study visits. The exercise prescription 
included providing the participant with a training HR, duration of aerobic exercise, types 
of aerobic exercise, and types/frequency of resistance exercise based on American 
College of Sports Medicine (ACSM) standards (American College of Sports Medicine et 
al., 2010). Training HR reflected the participant’s VC^max score rating of either poor, 
fair, good, or excellent with the training HR of 70%, 75%, 80%, or 85% of max HR 
respectively. Max HR was calculated as 220-age (years) (American College of Sports 
Medicine et al., 2010). Participants were instructed on how to take their radial pulse in 10 
seconds and were encouraged to take and record their pulse during their daily exercise 
bouts. Duration of exercise ranged from 10 minutes of daily aerobic exercise building up 
to 60 minutes of accumulated daily aerobic exercise. Frequency of aerobic exercise was 
set at everyday (5-7 days per week) for each participant, regardless of VC^max rating. 
Types of aerobic exercises prescribed were individualized to the participant to suit their 
needs; examples included, but were not limited to biking, walking, jogging, swimming, 
and hiking. Resistance exercise frequency ranged from one to three times per week with 
repetitions and sets increasing with fitness.
The final component of the individualized exercise prescription in the STEP™ protocol 
included a goal setting portion where the participant was assisted in setting two to three 
physical activity or health-related goals to be completed upon returning for the next visit. 
Goals were encouraged by using the SMART framework (specific, measurable, 
attainable, realistic, and timely) in addition to the inclusion of potential barriers and 
solutions (see Appendix B for exercise prescription, goals, and resistance sheets) (Schut 
& Siam, 1994).
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Quality o f  Life
After completion of STEP™, participants completed a QOL questionnaire, QOL was 
measured using the Short Form-36 (SF-36) questionnaire (Ware & Sherboume, 1992). 
The SF-36 has 36 questions and is divided into eight dimensions of QOL: physical 
functioning, role-physical, role-emotional, bodily pain, vitality, mental health, social 
functioning and general health. Raw scores are transformed using the guidelines 
developed by Medical Outcomes Trust and are then converted to a score out of 100 (0 
being having extremely poor QOL for a particular dimension, and 100 being having 
extremely good QOL for a particular dimension). The SF-36 has proven validity and 
reliability (Mchomey, Ware, & Raczek, 1993; Mchomey, Ware, Lu, & Sherboume,
1994) and was self-administered by the participants the way it was constructed to be 
administered (Ware & Sherboume, 1992).
Technologies/Pedometer
Each participant completed a 2 hour technology education session at baseline to ensure 
they were familiar with how to use each device. Manuals for each device were provided 
as well as a contact sheet for each participant should they require any technical assistance 
throughout the study.
The Blackberry™ (BlackBerry™ Curve 8300) was used as a data hub for BP measures 
which were sent wirelessly via a Bluetooth™ device connected to the BP monitor (A & D 
Medical #UA-767PBT). Pedometer steps were manually entered into the Blackberry™. 
Measurements were automatically transferred to a secure online database 
(Flealthanywhere™) where they could be monitored by researchers.
BP was measured on the left arm every Tuesday, Thursday and Sunday morning before 
breakfast by the participant using the provided BP monitor. When taking the 
measurement, participants were instructed to be in a seated position with feet flat on the 
ground, back supported, left arm supported and at a slight angle with palm up, in a room 
free of distractions (Campbell et al., 2010). BP measures were then sent wirelessly to the 
Blackberry™.
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Steps per day were recorded at the end of each day on the provided pedometer (Omron # 
HJ-150) and manually entered into the Blackberry™ before going bed. Pedometers had a 
7 day memory so steps could be entered for previous days if missed. Participants were 
also provided with an activity log on their Blackberry™ where they could enter their 
daily physical activity and HR from a list of personalized and pre-selected activities. 
Pedometer data was analyzed as weeks 1-12 vs. weeks 13-24 to see if the STEP™ 
increased steps from the first 3 months of the study to the last 3 months.
Once data was entered or sent to the Blackberry™, all data could be reviewed and/or 
retrieved at any time by research personnel on a password protected website 
(Healthanywhere™, IgeaCare Inc.).
Statistical Analysis
Differences between VO, VI and V2 were analyzed for each variable using a repeated 
measures multivariate analysis of variance (MANOVA) as well as paired t-tests to 
compare home versus clinic data. Partial eta squared (tj p) was used to display the 
variability accounted for in the treatment effect, unique to this study interaction. All 
statistical analysis was done with PSAW (version 18, SPSS Inc., Chicago, IL), accessed 
through the University of Western Ontario VLab, and significance was set at /?<0.05. All 
values are presented as mean±SD.
2.3 Results
A total of 211 individuals were contacted for this study, 128 were deemed eligible and 61 
were randomly assigned to the STEP™ and technology group. Ineligibility was due to the 
failure to meet inclusion/exclusion criteria or individuals made initial contact with the 
researchers, but failed to return calls or emails to determine eligibility. Fifty five of the 61 
participants recruited completed all three study visits. Six participants dropped out of the 
study after baseline. Reasons for drop-out included no time (n = 2), too much burden (n = 
2), not feeling monitored (n = 1) and unknown (n = 1). Values missing completely at 
random were imputed using last outcome carried forward (n = 2).
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Participant Characteristics
At VO, the 55 participants had a mean age of 56.9±10.1 years and 70.9% were female. 
Table 2.1 outlines the baseline characteristics of the participants. Seventeen participants 
were on BP medication before starting the study and did not change the dosage or start a 
new medication throughout the intervention period; the majority of BP medications were 
angiotensin-converting enzyme inhibitors. Another seven participants changed, started, or 
stopped using BP medication during the study in which case a separate ANOVA was run 
(two participants changed BP medication after VO, three participants started using BP 
medication after VO, and two participants stopped using BP medications after VO) to see 
if the pattern of change matched clinical BP. Average clinical SBP and DBP were 
143.4±18.3 mmHg and 88.Ü10.3 mmHg at VO, respectively, and RHR was 67.7±9.4 
bpm (Table 2.1). At-home BP was averaged during the week following VO and was 
130.8Ü5.9 mmHg for SBP and 83.9±10.2 mmHg for DBP (Table 2.1). Average WC, 
weight and BMI at VO were 106.6±12.6 cm, 91.7±16.5 kg and 32.8±5.2 kg/m2, 
respectively (Table 2.1). All variables had equal sample sizes at each visit (n = 55).
At baseline, participants had an average of 2.9 MetS risk factors which did not 
significantly decrease throughout the study [F(l, 54) = 1.50, n.s]. The majority of 
participants had two risk factors (36.4%), followed by three (29.1%) and four (23.6%) 
risk factors and a small number with one (5.5%) and five (5.5%) risk factors. The most 
prevalent risk factors were waist circumference and BP followed by HDL and 
triglycerides with a small portion of the sample meeting the fasted blood glucose risk 
factor cut-off for MetS (Table 2.2).
Effects o f  STEP™ on clinical blood pressure, fitness, and anthropometries at 3 and 6 
months
At V2, STEP™ had a significant effect on clinical BP, whereby, clinical SBP decreased 
from 143.4±18.3 mmHg at VO to 138.2±16.6 mmHg at VI [F(l, 54) = 4.84,/?<0.05, =
0.082] and to 132.7Ü3.0 mmHg at V2 [F(l, 54) = 1.55,p<0.05, = 0.123] (Figure
2.1), for a total decrease of 10.7 mmHg. Clinical DBP showed a significant decrease from
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88.1±10.3 mmHg at baseline to 84±10.3 mmHg at VI [F(l, 54) = 12.20,/?<0.05, rj2 p = 
0.184] and continued to decrease to 81.3±9.4 mmHg at V2 [F(l, 54) = 6.16,/?<0.05, rj1 p = 
0.102], for a total decrease of 6.8 mmHg.
A separate analysis was run excluding individuals who had changed, started, or stopped 
their BP medication throughout the study (n = 48). This analysis was the same as 
previously mentioned aside from a loss in significance from VI to V2 for clinical DBP (p 
= 0.054).
Predicted VC^max showed a significant increase from V0 to VI, [F(l, 54) = 8.78, 
/?<0.05, rj2 p = 0.140] (30.7±7.3 ml/kg/min vs. 32.3±7.4 ml/kg/min, respectively; Figure 
2.2) and remained elevated at V2. There was no change seen in RHR from V0 to VI,
[F(l, 54) = 1.31, n.s.], or from VI to V2, [F(l, 54) = 2.77, w.s]. There was however, a 
significant change in RHR from V0 to V2, [F(l, 54) = 8.03,/?<0.05, tj2p■= 0.129] 
(67.7±9.4 bpm vs. 64.7±9.2 bpm, respectively).
Average weight decreased significantly from 91.7±16.5 kg at V0 to 90.2±16.0 kg at VI, 
[F(l, 54) = 19.02, jO<0.05, rj2 p = 0.260], and remained significantly lower than baseline 
following 6 months of training (V2, [F(l, 54) = 1.95, n.s.]', Figure 2.3). The average 
change in BMI followed the pattern of change in weight with a significant decrease from 
V0 to VI, [F(l, 54) = 19.09,/?<0.05, rj2 p = 0.261] (32.8±5.2 kg/m2 vs. 32.3±4.9 kg/m2) 
and remained low at V2 [F(l, 54) = 2.03, «.5.] (Figure 2.3). WC however showed a 
continuous decrease throughout the study. WC decreased from 106.6± 12.6 cm at V0 to 
104.4±12.0 cm at VI, [F(l, 54) = 7.55,p<0.05, tj2p = 0.123] to 100.4±14.3 cm at V2, 
[F(l, 54) = 6.39, ̂ <0.05, rj2 p = 0.106] (Figure 2.3).
Effects o f  STEP™ on at-home blood pressure and pedometer steps
At-home SBP significantly decreased from V0 to VI, [F(l, 54) = 6.78,/?<0.05, rf p =
0.112] (130.8±15.9 mmHg vs. 126.7±13.0 mmHg, respectively decreasing 4.1 mmHg) 
and remained low at V2 [F(l, 54) = 3.68, n.s.]. At-home DBP decreased from 83.9±10.2 
mmHg at V0 to 81.6±9.3 mmHg at VI, [F(l, 54) = 5.68,/><0.05, rj2 p = 0.095], and
continued to decrease to 79.6±9.5 mmHg at V2, [F(l, 54) = 7.65,p<0.05, rj2 p = 0.124] 
(Figure 2.4), decreasing 4.3 mmHg. At-home BP was significantly lower than clinical BP 
for each visit except for V2 where there was no significant difference between at-home 
and clinical DBP, [¿(54) = 1.568, «.$.].
A separate analysis was run excluding individuals who had changed, started, or stopped 
their BP medication throughout the study (n = 48). This analysis found a significant 
decrease in at-home SBP from baseline to V2 only, [F(l, 47) = 11.54, p<0.05, //2P = 
0.197] (129.5Ü5.5 mmHg vs. 124.3±13.1 mmHg, respectively), while at-home DBP 
showed a significant decrease from VI to V2, [F(l, 47) = 5.97,p<0.05, rj2p = 0.113] 
(81.6Ü9.3 mmHg vs. 79.7±9.3 mmHg, respectively).
Daily physical activity, measured with pedometers as steps per day showed a significant 
increase in the average number of steps per day in weeks 1 through 12 with 
7940.9±2781.6 steps/day increasing to 8475.7±2627.5 steps/day in weeks 13-24, [/(54) = 
2.857,p<0.05] (Figure. 2.5).
Effects o f STEP™ on quality o f life
There was no significant change in the QOL SF-36 questionnaire as a whole [F(16, 36) = 
1.598, n.s.]. However, looking at the specific domains of the SF-36, there were 
significant improvements in the areas of vitality, mental health, and general health. 
Vitality increased from a score of 59.3±18.8% at baseline to 64.8±16.4% at VI, [F(l, 51) 
= 6.03,p<0.05, tj2 p = 0.106], and remained elevated at V2. Improvements in mental 
health followed a similar pattern, with a score of 79.0±13.6% at V0 increasing to 
83.6±11.6% at VI, [F(l, 51) = 9.52,p<0.05, rj2p = 0.157], and no increase from VI to 
V2. General health increased from V0 to V2 [71.7±16.3% vs. 77.5±13.4%, respectively, 
F (l, 51) = 13.31,p<0.05, f]2p = 0.207], but not at VI (Figure 2.6). Sample sizes for each 
domain were equal (n = 52). If a questionnaire or a score within a domain were missing 




Table 2.1. Participant baseline characteristics
Mean ± SD
Age (year) 56.9 ± 10.1
Clinical SBP (mmHg) 143.4 ± 18.3*
Clinical DBP (mmHg) 88.1 ± 10.3*
At-home SBP (mmHg) 130.8 ± 15.9
At-home DBP (mmHg) 83.9 ± 10.2
Resting heart rate (bpm) 67.7 ± 9.4
VC^max (ml/kg/min) 30.7 ±7.3
Waist circumference (cm) 106.6 ± 12.6
Weight (kg) 91.7 ± 16.5
BMI (kg/m2) 32.8 ± 5.2
n = 55, * significantly higher than at-home BP measures. p<0.05.
Table 2.2. Participant MetS risk factor distribution at baseline
MetS Risk Factors




















Figure 2.1 Clinical BP changes over 6 months. Solid line represents SBP and dotted line 
represents DBP. All values are means±SD. * significant difference from VO.§ significant 
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Figure 2.2. VC^max and RHR changes over 6 months. Solid line represents VC^max and 
the dotted line represents RHR on the secondary (right hand) axis. All values are 








WT (kg) BMI (kg/m2) WC (cm)
■ VO E3VI □ V2
Figure 2.3. Change in anthropometries over 6 months. WT; weight, BMI; body mass 
index, WC; waist circumference. All values are means±SD. * significant difference from 
VO.§ significant difference from V I. p<0.05.
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Figure 2.4. At-home BP changes over 6 months. Solid line represents SBP and dotted line 
represents DBP. All values are means±SD. * significant difference from VO. § significant 















■ Weeks 1-12 □ Weeks 13-24
Figure 2.5. Change in pedometer steps from weeks 1-12 to weeks 13-24 of intervention. 






Figure 2.6. Change EL 
in the domains of the 
SF-36 questionnaire 
over 6 months of 
intervention. All 
values are
means±SD. n = 52. * 
significant difference g1 























This study illustrates the effects of a 6 month aerobic-based, technology supported 
physical activity program prescribed at the primary care level to adults from rural Ontario 
with MetS who are at a high risk of CVDs. The reduction in BMI, weight, and WC 
following this exercise prescription was similar to what is expected in an exercise 
prescription provided at the primary care level for individuals with MetS (Aizawa et al., 
2009). Specifically, this study was designed to examine the change in both SBP and 
DBP, as well as fitness measured using the STEP™ and QOL for individuals at risk for 
T2D and CVD in a primary care setting with remote monitoring technology. We 
observed significant decreases in BP (clinical and at-home), WC, BMI, weight and RHR, 
as well as increases in fitness and the vitality, mental health, and general health domains 
in QOL. To our knowledge, this is the first study to show a significant change in both 
SBP and DBP as wells as QOL, using aerobic and resistance exercise in combination 
with technology in rural subjects with MetS.
A review by Fagard (1993) identified 39 papers on the effect of dynamic exercise on BP 
in healthy normotensive or hypertensive subjects. It was found that BP, in response to 
training, decreased -5.3 mmHg in SBP and -4.8 mmHg in DBP. These changes are very 
similar to the significant decreases seen in at-home BP in the present study. Another 
meta-analysis in 2001 compared different training regimes to treat or prevent 
hypertension (Fagard, 2001). The results showed that exercise training, 30-60 minutes, on 
most days of the week reduced BP, particularly in hypertensives, and that training at a 
moderate intensity was similar to training at a hard intensity (40-85% of net maximal 
exercise or VC^max reserve). Intensity in the present study was determined through 
predicted VC^max as a percent of maximal HR. The results of the current study are in 
agreement with the two previously mentioned studies, where the average decrease in 
home SBP and DBP were in the expected range for an aerobic exercise program.
Comparing clinic and at-home BP, it was expected that the BP taken at the clinic would 
be higher than at-home BP (Laughlin, Sherrard, & Fisher, 1980; Mancia et al., 2007). 
However, the lack of a significant decrease in at-home SBP between VI and V2,
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compared to clinic SBP, could potentially be due to familiarisation of the participants to 
the clinical testing procedure at V2 and therefore resulting in decreased clinic SBP 
(Felmeden, Lip, Beevers, & Beevers, 2000). This would imply that our intervention did 
not continue to have an effect on at-home SBP post 3 months but rather maintained the 
reduction achieved half-way through the intervention.
In contrast to our findings, Church et al. (2007) found that overweight or obese women 
with elevated BP did not experience a change in BP with increases in exercise levels. 
They did however, see a significant improvement in VC^max following 6 months of 
supervised exercise training. The authors mentioned that the lack of change in BP seen in 
their study was likely due to their participants being asked not to change any of their 
lifestyle habits outside of the study. While the women in the Church et al. study were not 
classified as having MetS, their baseline values provide evidence that, on average, they 
possessed the necessary risk factors to be diagnosed as having MetS. Although we did 
not offer any lifestyle advice apart from increasing exercise and providing Canada’s Food 
Guide, our participants may have been motivated to live healthier lifestyles in accordance 
to their individualized exercise programs and goal setting.
The results of the present study support improvements in VC^max after 3 months of 
aerobic training, the increase of which was maintained (but not further augmented) with 
an additional 3 months of training. Other studies that reported a continued increase in 
fitness with exercise training have used supervised, scheduled exercise training sessions 
or classes (Carroll et al., 2007; Church et al., 2007) rather than physical activity 
prescribed to an individual. Individuals with MetS experience similar changes in V02max 
with training as those without MetS (Katzmarzyk et al., 2003) and therefore absence of 
an increase in V02max post 3 months seen in our population may be attributed to the lack 
of continued increase in the intensity of their activities (Church et al., 2007). However, 
the STEP™ with home-monitoring technology was able to maintain the improved fitness 
of our participants throughout the remainder of the study. One study that used exercise 
counselling versus exercise training showed an increase in 6 month fitness levels 
(measures in METs) in both control and intervention groups from baseline thereby
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supports the use of counselling within the STEPIM intervention (Dunn et al., 1997). The 
results of the present study also showed an increase in VC^max at VI from VO.
Confirming our results of a decrease in both SBP and DBP at VI, a review by Hagberg et 
al. (2000) found that reductions in BP could be observed early in an exercise intervention. 
Specifically, reductions in both SBP and DBP could be evident after only 1 to 10 weeks 
of aerobic training in hypertensive adults. However, Hagberg et al. also found that SBP 
has been shown to progressively decrease over the length of the training period (1-20 
weeks) while DBP shows a decrease in the first 1-10 weeks of an exercise training 
program with a lack of a decrease seen in weeks 11-20. This time course of improvement 
was opposite to what we found in our at-home BP readings. While decreased BP with 
increased exercise has been shown to be consistent in individuals with MetS (Carroll et 
al., 2007; Katzmarzyk et al., 2003), we observed a continuous improvement in at-home 
DBP while SBP declined early in the intervention and remained suppressed following 6 
months of intervention. This could be attributed to the fact that VC^max also did not 
continue to improve post 3 months and SBP may follow the change in fitness more 
closely than DBP. Carroll et al. (2007) found an increase in VC^max with their exercise 
intervention for MetS (+1.66 ml/kg/min) very similar to the increase seen in the present 
study (+1.6 ml/kg/min), yet Carroll et al. saw a significant decrease in DBP only at 3 
months. The data from Hagberg et al. (2000) was collected on individuals with 
hypertension (BP >140/90 mmHg) and therefore may explain why they expected a 
prolonged decrease in SBP. Since the participants in the present study were not required 
to have hypertension (at V0, 63.6% of participants were hypertensive in clinic and 57.2% 
were hypertensive at-home [at-home hypertension classified as SBP >135 mmHg or DBP 
>85] according to the 2010 CHEP recommendations; Campbell et al., 2010), the 
reduction of SBP might not be continuous with training since hypertensive individuals 
experience a greater decrease in BP with exercise training than normotensive or pre­
hypertensive individuals (Fagard, 1993).
The addition of the technology to the present study provided the participants with home 
monitoring devices that allowed for feedback on their exercise habits with respect to the
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changes in their BP and pedometer steps. The improvement seen in at-home BP in our 
participants is consistent with other studies that have used a cell-phone or internet in 
combination with exercise counselling to promote improved BP (Park et al., 2009). 
However, another study using only remote BP monitoring and no exercise counselling 
also found a decrease in BP over time (4 months) (Logan et al., 2007). There were, 
however, coaching messages sent automatically to the mobile phone after every reading 
that encouraged participants to follow a healthy lifestyle if a BP reading was above their 
individual goal. These messages, as well as the fact that the individual treatment of a 
participant was at the discretion of their own attending physician, may have attributed to 
the decrease in BP as much as the use of the technology itself. In the present study we did 
not provide detailed activity changes or counselling to participants between visits if there 
was a lack of improvement in BP.
The slight change in weight, and in turn BMI, was normal as current research has found 
modest weight loss in lifestyle modifications that promote physical activity without 
supervised exercise training (Jakicic et al., 2011; Ross & Bradshaw, 2009). In the present 
study, there was no dietary prescription or changes made to the dietary habits of the 
participants. Had there been a diet or caloric restriction in the present study, a greater 
change in weight beyond 3 months of the intervention may have been expected (Aizawa 
et al., 2009; Jakicic, 2009). However, a significant improvement in the WC of the 
participants throughout the 6 months of our intervention was observed, a finding which is 
somewhat more important for MetS risk factor reduction than weight or BMI. Abdominal 
obesity, measured by WC, is a risk factor of MetS as well as a strong predictor of heart 
disease on its own (Alberti, Zimmet, & Shaw, 2006). The importance of abdominal 
obesity and its relationship to CVD and T2D is portrayed in the International Diabetes 
Federation definition of MetS, which was designed for clinical use, where an increased 
WC is a risk factor an individual must possess in order to be diagnosed as having MetS 
(Alberti et al., 2006).
With respect to QOL, the significant increases in the domains of vitality, mental health, 
and general health with the STEP™ are encouraging. A similar study that used an
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exercise intervention in a rural population of women with MetS also found significant 
improvements in physical function, vitality, mental health and general health using the 
SF-36 QOL questionnaire (Oh et al., 2010). The intervention used in the Oh et al. (2010) 
study included supervised exercise and diet that the STEP™ did not, therefore, the 
similar increases seen with the STEP™ intervention may suggest that the lack of 
supervised exercise does not decrease an individual’s perception of their general health.
There are limitations to the present study. First, the results of the intervention were not 
compared to a control group and therefore there is potential that the results are due to 
regression to the mean in addition to the effect of the intervention itself. Second, due to 
our study design being mostly pragmatic, individuals who started, stopped or changed 
their medication throughout the study were not excluded from the analysis and may have 
contributed to changes seen in BP throughout the study. However, this design allows for 
greater generalizability of our study since changes in BP medication are relatively 
common amongst older adults, as seen in our subjects where medication changes were at 
the discretion of their own physicians. Third, dietary changes were not monitored 
throughout the study and therefore it is not known if any of our participants experienced a 
change in BP, WC or weight mainly due to a decrease in caloric or sodium intake rather 
than an increase in the physical activity. Participants were not instructed to change their 
dietary habits throughout the study aside from being provided with the Canadian Food 
Guide (Health Canada, 2007) and therefore, it was assumed that any changes to diet were 
minor. Fourth, not all of the participants used the technology to the same degree. 
Participants were reminded throughout the study by automatic short message service 
reminders to perform their BP readings and enter their pedometer steps according to the 
given schedule. On occasion, study researchers would contact a participant to confirm 
that technical issues were not the reason behind multiple missed readings; however 
compliance with the technology was not forced throughout the study and no individuals 
were withdrawn from the study for lack of compliance. Fifth, pedometers were the only 
means of tracking the exercise performed by the participants and therefore may have 
missed activities that were not recorded by the pedometer such as swimming, biking and 
aerobic machines such as the elliptical. Participants were provided with an activity log
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application on their BlackberryIM where they could record their daily activities (aerobic 
and resistance), however activity log data remains to be analyzed. Sixth, staff turnover in 
this study may have led to potential variations in measurement techniques of the primary 
and secondary outcome measures. Seventh, the somewhat small sample size may have 
resulted in Type I error. Our sample size calculation was performed based on an 
estimation of a 5.3 mmHg reduction in SBP. Lastly, the use of technology in conjunction 
with the STEP™ showed improved BP in this study, however it is unknown if the 
exercise prescription at the primary care level, the technology in rural care, or better 
management of BP by subjects’ physicians during the study was the main cause of 
improved BP.
2.5 Conclusion and implication
In conclusion, this study has demonstrated that, in rural populations with MetS, an 
aerobic based exercise program using STEP™ at the primary care level in conjunction 
with at-home monitoring improved resting BP, fitness, QOL, weight, BMI and WC at 3 
months and continued to improve DBP and WC into 6 months. Further studies in 
ARTEMIS will be to determine if the STEP™ in combination with technology is as 
effective in a control group of the same population without the use of technology. Since a 
lifestyle modification that includes exercise and a healthy diet are the first line of therapy 
for individuals at risk for CVD and T2D, future studies will improve the transition of 
implementing additional resources into primary care for these modifications to take place.
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Step Test VChmax Calculation and Ratings
Patient Data
Sex male = 1 female = 2
Age ____________ years
Weight ____________ kg
Time required for Step Test ____________ seconds
Heart rate after Step Test ____________ beats/min
Calculations
Step 1: (1511 / time) * weight / heart rate =
t
Step 2: ( _____* 0.124) -  (age * 0.032) -  (sex * 0.633) + 3.9
i
Step 3: ( _____* 1000) / weight = V02max
60
Age V02max(ml/kg/min) Rating Heart Rate Prescription
Female 18-29 <31 Poor 70% of max HR
18-29 32-34 Fair 75% of max HR
18-29 35-37 Good 80% of max HR
18-29 >38 Excellent 85% of max HR
Male 18-29 <37 Poor 70% of max HR
18-29 38-41 Fair 75% of max HR
18-29 42-44 Good 80% of max HR
18-29 >45 Excellent 85% of max HR
Female 30-39 <29 Poor 70% of max HR
30-39 30-32 Fair 75% of max HR
30-39 33-35 Good 80% of max HR
30-39 >36 Excellent 85% of max HR
Male 30-39 <35 Poor 70% of max HR
30-39 36-39 Fair 75% of max HR
30-39 40-42 Good 80% of max HR
30-39 >43 Excellent 85% of max HR
Female 40-49 <27 Poor 70% of max FIR
40-49 28-30 Fair 75% of max HR
40-49 31-32 Good 80% of max HR
40-49 >33 Excellent 85% of max HR
Male 40-49 <33 Poor 70% of max HR
40-49 34-37 Fair 75% of max HR
40-49 38-40 Good 80% of max HR
40-49 >41 Excellent 85% of max HR
Female 50-59 <24 Poor 70% of max HR
50-59 25-27 Fair 75% of max HR
50-59 28-29 Good 80% of max HR
50-59 >30 Excellent 85% of max HR
Male 50-59 <30 Poor 70% of max HR
50-59 31-34 Fair 75% of max HR
50-59 35-37 Good 80% of max HR
50-59 >38 Excellent 85% of max HR
Female 60+ <23 Poor 70% of max HR
60+ 24-25 Fair 75% of max HR
60+ 26-27 Good 80% of max HR
60+ >28 Excellent 85% of max HR
Male 60+ <26 Poor 70% of max HR
60+ 27-30 Fair 75% of max HR
60+ 31-34 Good 80% of max HR
60+ >35 Excellent 85% of max HR
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Appendix B.
ARTEMIS -  Fitness Test Results and Prescription 
Results and Exercise Prescription_____ ______________ Participant ID:
V02max Score
V02max Rating
Training Heart Rate (bpm)
Training Heart Rate (10 seconds)
Target Aerobic Exercise Duration
Target Aerobic Exercise Frequency
Types of Aerobic Exercises
Types of Resistance Training Exercises
Definitions
VC>2 inax -  This is a measure of your cardiorespiratory fitness. It is a score of how well 
your heart, lungs, and muscles work together, the higher the number is, the more fit you 
are, you can become more fit by increasing your aerobic physical activity. Some 
examples of aerobic physical activity include walking, swimming, or shovelling the 
driveway.
Training Heart Rate -  In order to improve your fitness, it is important to check your 
heart rate during physical activity. This training heart rate has been prescribed 
specifically for you based on your exercise results. The easiest way to check your pulse is 
to count how many times you feel your heart beat in 10 seconds.
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Participant Goals/Barriers/Solutions
Write down 2-3 physical activity or health related goals that you want to achieve. 
Remember to make them specific, measurable, attainable, realistic, and timely. For each 
goal, identify barriers that will prevent you from reaching your goal. Barriers can be 
things that you cannot control, such as the weather. For each barrier, identify how you 
plan to overcome that barrier. For example, you might overcome bad weather by
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Activity Level: Sedentary
Do each activity two times per week.
1 set, and 12 repetitions of each:
1) Wall push ups
2) Sit to stands
3) Abdominal exercises
4) Calf raises
Activity Level: Somewhat Active
Do each activity two times per week.
2 sets, and 12 repetitions of each:
1) Wall push ups
2) Sit to stands
3) Abdominal exercises
4) Calf raises
Do each activity two or three times per week.
3 sets, and 12 repetitions of each:
1) Wall push ups
2) Sit to stands
3) Abdominal exercises
4) Calf raises
2 sets, and 12 repetitions of each:
5) Lunges
6) Bicep Curls
Activity Level: Moderately Active
7) Tricep Dips
Do each activity three times per week.
3 sets, and 12 repetitions of each:
1) Wall push ups
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